Bausch Health Companies BHC
NYSE BHC
$5.80 +0.08 (+1.40%)
At close: Oct 2, 2026 · 4:00 PM EDT

Bausch Health Companies (BHC) Cost of Revenue (2009 - 2026)

Updated

Bausch Health Companies (BHC) posted Cost of Revenue of $772 million for Q2 2026, up 1.0% from $764 million a year earlier and up 4.6% from the prior quarter.

Analysis

Bausch Health Companies (BHC) Cost of Revenue (2009 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Cost of Revenue at Bausch Health Companies was $3.06 billion, up 5.9% year-over-year; for FY2025, it came in at $3.01 billion, up 8.3% from FY2024.

  • Annual Cost of Revenue has increased for three consecutive years, with a five-year compound annual growth rate of 6.0% (FY2020 to FY2025).
  • In prior years, Bausch Health Companies' Cost of Revenue was $2.78 billion in FY2024 (+8.7%), $2.56 billion in FY2023 (+8.2%), $2.36 billion in FY2022 (-1.3%) and $2.39 billion in FY2021 (+6.4%).
  • Quarterly Cost of Revenue has run from a low of $551 million in Q1 2022 to a high of $798 million in Q4 2025 over five years.
  • On a year-over-year basis, Cost of Revenue has increased in each of the last 16 quarters, with growth averaging 6.8% over the last eight quarters.
  • The strongest year-over-year quarter for Cost of Revenue in the past five years was Q2 2023, with growth of 12.5%; the weakest was Q2 2022, with a decline of 5.7%.
  • According to Business Quant data, Cost of Revenue for the three prior quarters was $738 million (Q1 2026), $798 million (Q4 2025) and $750 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cost of Rev (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 3.27 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 8.05 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 4.29 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 4.40 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 3.71 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 2.52 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 2.81 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 1.58 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 4.09 Bn
10 Bausch Health Companies 2.17 Bn -2.60 Bn 2.08 Bn 772.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 772.00 Mn
Mar 31, 2026 738.00 Mn
Dec 31, 2025 798.00 Mn
Sep 30, 2025 750.00 Mn
Jun 30, 2025 764.00 Mn
Mar 31, 2025 701.00 Mn
Dec 31, 2024 727.00 Mn
Sep 30, 2024 696.00 Mn
Jun 30, 2024 719.00 Mn
Mar 31, 2024 640.00 Mn
Dec 31, 2023 705.00 Mn
Sep 30, 2023 623.00 Mn
Jun 30, 2023 649.00 Mn
Mar 31, 2023 582.00 Mn
Dec 31, 2022 652.00 Mn
Sep 30, 2022 584.00 Mn
Jun 30, 2022 577.00 Mn
Mar 31, 2022 551.00 Mn
Dec 31, 2021 626.00 Mn
Sep 30, 2021 582.00 Mn
API Access

Bausch Health Companies Cost of Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=BHC&period=max&api_key=YOUR_API_KEY